Pelvic organ prolapse

Pelvital Announces Advisory Board, Fueling its Mission to Transform the Standard of Care for Urinary Incontinence

Retrieved on: 
Tuesday, April 2, 2024
University, Obstructive sleep apnea, Patient, Pelvic pain, Vocational education, Urodynamic testing, Engineering, Gender, Champaign–Urbana metropolitan area, Pelvic organ prolapse, Carlson School of Management, UnitedHealth Group, Incontinence, Woman, Safety, Strategic communication, Organization, Biomedical engineering, Advisory board, Neurology, Female, Sport, Associate, Research, MD, UIT, Tetraplegia, Urinary incontinence, Biology, Book, FDA, Medtech, Health, Visibility, Growth, Computational biology, Arizent, Mechanical engineering, Physiology, M Health Fairview, Doctor of Philosophy, Integrative Biology, Faculty, Urogynecology, Human, MBA, News, Government, Rehabilitation, Nursing

EAGAN, Minn., April 2, 2024 /PRNewswire-PRWeb/ -- Pelvital, the women's health MedTech company on a mission to transform the standard of care for urinary incontinence, is proud to announce the formation of its formal scientific and business advisory board. This dynamic team of industry leaders and experts will play a pivotal role in supporting the strategic direction and growth of the organization in its ongoing efforts to expand its reach with clinicians, patients, and payors seeking an effective, accessible, conservative treatment option.

Key Points: 
  • EAGAN, Minn., April 2, 2024 /PRNewswire-PRWeb/ -- Pelvital, the women's health MedTech company on a mission to transform the standard of care for urinary incontinence, is proud to announce the formation of its formal scientific and business advisory board.
  • The seven-person advisory board assembles a wealth of experience and expertise with each member having a proven track record of excellence.
  • Dr. Alpert has taught for many years in entrepreneur programs at U.S. and overseas universities, mentoring students and faculty working in the healthcare industry.
  • Their collective knowledge and experience will be instrumental in guiding Pelvital as we embark on an exciting phase of growth and innovation."

Visa Announces Sixth Round of She’s Next Grant Program recipients, spotlighting the next generation of women entrepreneurs

Retrieved on: 
Friday, March 8, 2024
Come, Anxiety, Empathy, Sikhs, Woman, Livestock, Failure, Small business, Marketing, Horticulture, Quality of life, Visa, Female, Grain, DRE, Government, System, Clothing, CAD, Puberty, SME, Beer, Paratriathlon, Knowledge, Panic, Pelvic organ prolapse, QC, Waste management, Face, Toy

TORONTO, March 08, 2024 (GLOBE NEWSWIRE) -- Today, Visa Canada announced the recipients of its She’s Next Grant Program.

Key Points: 
  • TORONTO, March 08, 2024 (GLOBE NEWSWIRE) -- Today, Visa Canada announced the recipients of its She’s Next Grant Program.
  • Aiming to uplift women-owned small businesses, the program awards 10 winners a $10,000 CAD grant and access to an accelerated mentorship program through York University’s YSpace.
  • The She’s Next Grant Program builds on our track record of supporting small businesses and recognizes women face a myriad of challenges on the road to success,” said Sarah Steele, Senior Director, Small Business Product at Visa.
  • Customers can buy, sell and discover clothing made specifically for tall women with access to over 20 tall brands and counting.

Caldera Medical awarded Specialty Women’s Health and Surgical Incontinence contract Agreement with Premier Inc.

Retrieved on: 
Wednesday, December 20, 2023
Medical Supplies, Health, Medical Devices, Consumer, Women, Surgery, Biotechnology, Medicine, Polyp, Pelvic organ prolapse, SKU, Biodegradable waste, Hospital, Woman, Fibroid, Urinary incontinence

Caldera Medical is thrilled to announce it has been awarded a national group purchasing agreement for Surgical Incontinence beginning on January 1, 2024, and Specialty Women’s Health Products with Premier, Inc.

Key Points: 
  • Caldera Medical is thrilled to announce it has been awarded a national group purchasing agreement for Surgical Incontinence beginning on January 1, 2024, and Specialty Women’s Health Products with Premier, Inc.
  • Effective February 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier.
  • This initiative underscores Caldera's continued increase in investment to provide Premier facilities unwavering commitment to consistent supply and a strong focus on domestic manufacturing.
  • Its universal compatibility with all scopes and fluid management systems underscores Caldera's commitment to versatile and innovative health care solutions.

PFD Week Abstracts Show Leva’s Long-Term Treatment Value for Female Urinary Incontinence Plus New Data for Other Pelvic Floor Disorders

Retrieved on: 
Friday, October 6, 2023
Medical Devices, Health, Consumer, Hospitals, Women, Clinical Trials, The Green Journal, Nursing, Food, Female, Doctor of Philosophy, Abstract, Research, Prevalence, Urinary incontinence, PFMT, MD, Randomized controlled trial, Insurance, PFD, University, Massachusetts General Hospital, Hospital, Storey, Pelvic floor, Pelvic organ prolapse, FDA, Incontinence, FI, Harvard Medical School, POP, Vagina, Fecal incontinence, RCT, UI, Regulation of tobacco by the U.S. Food and Drug Administration, Woman, Richter, Quality of life, Birth control, Pharmaceutical industry, Dietary supplement, Gynaecology, Obstetrics

The Leva System is a non-drug, non-surgical treatment that helps women strengthen their pelvic floor at home, on their own schedule, by guiding correct and consistent pelvic floor muscle training (PFMT).

Key Points: 
  • The Leva System is a non-drug, non-surgical treatment that helps women strengthen their pelvic floor at home, on their own schedule, by guiding correct and consistent pelvic floor muscle training (PFMT).
  • The researchers presented their data in two abstracts during PFD Week 2023, the American Urogynecologic Society’s (AUGS) annual scientific meeting held in Portland, Ore. Oct. 4-6, 2023.
  • “We do, and it provides powerful validation of the Leva Pelvic Health System’s treatment value for women.
  • The research also showed that women with multiple pelvic floor disorders had more severe UI symptoms than women with UI only.

Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

Retrieved on: 
Wednesday, September 6, 2023
Medical Devices, Surgery, Medical Supplies, Women, Biotechnology, General Health, Consumer, Health, Science, Other Science, Urinary incontinence, Medicine, Pelvic organ prolapse, SUI, Quality of life, Polyp (zoology), Woman, Pelvic floor, Acquisition, Patient, FDA, Therapy, Atlantic Ocean, Pharmaceutical industry, Fibroid

The acquisition bolsters Caldera Medical’s expanding portfolio, furthering its mission to improve the quality of life for women!

Key Points: 
  • The acquisition bolsters Caldera Medical’s expanding portfolio, furthering its mission to improve the quality of life for women!
  • By acquiring Atlantic Therapeutics, Caldera Medical adds the commercial leading non-invasive, FDA cleared, Innovo product family as a first-line therapy for women with stress urinary incontinence.
  • Caldera Medical will maintain a European headquarters and innovation center in Galway, Ireland.
  • I am delighted that we will see Innovo thrive within Caldera Medical and want to thank Bryon and the team for their dedication to women’s health.”

Enhancing Patient Outcomes: Surge in Breast Reconstruction Drives Growth of Global Reconstruction Meshes Market to 2033 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 6, 2023
Biotechnology, Health, Surgery, Tissue, ASP, Patient satisfaction, Internet, COVID-19, Market access, Country, CMO, Strategic planning, Implant, SWOT, Mastectomy, Investment, Reading, SWOT analysis, Breast, Growth, Region, Epidemiology, LIBOR market model, Pelvic organ prolapse, General surgery, Forecast, Safety, Breast reconstruction, Urinary incontinence, Retail, Medical imaging, Health care, Risk management

The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.
  • The breast reconstruction market is increasing dramatically due to improvements in patient satisfaction, reduced costs, and decreases in side-effects from procedures.
  • Use of repair meshes along with breast implants is emerging as an effective method for breast reconstruction after mastectomy.
  • Global, Regional and Country level market specific insights:
    Qualitative market specific information is available with global trends further broken down into regional trends.

First robotic surgery for pelvic organ prolapse performed at Covenant High Plains Surgery Center

Retrieved on: 
Wednesday, August 9, 2023
Infection, Abdomen, Patient, Pelvic organ prolapse, Risk, Hospital

LUBBOCK, Texas, Aug. 9, 2023 /PRNewswire/ -- Covenant High Plains Surgery Center (CHPSC) announced Dr. Ryan C. Owen has completed the first robotic sacrocolpopexy in an independent freestanding surgery center in West Texas.

Key Points: 
  • LUBBOCK, Texas, Aug. 9, 2023 /PRNewswire/ -- Covenant High Plains Surgery Center (CHPSC) announced Dr. Ryan C. Owen has completed the first robotic sacrocolpopexy in an independent freestanding surgery center in West Texas.
  • Sacrocolpopexy is performed to treat pelvic organ prolapse, which occurs when the connective tissues or muscles within the body cavity are weak and unable to hold the pelvis in its natural orientation.
  • The traditional approach is an open surgery through a 6-8-inch incision in the abdomen, but robotic surgery offers the advantages of smaller incisions, faster recovery, less pain, and decreased risk of infection.
  • This was something unheard of not too long ago, and now it's available to everyone who needs this advanced level of quality care."

FEMSelect Launches Consumer Advocacy Campaign To Raise Awareness and Highlight Treatment Options for Pelvic Organ Prolapse

Retrieved on: 
Thursday, August 3, 2023
Communication, Pelvic organ prolapse, Education, Friends, Pelvis, Woman, Research, Uterus, Embarrassment, Consumer, Rectum, Physician, Ageing, Health, Family, Birth control, Medical device

NEWARK, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- FEMSelect Ltd., a women-led company developing groundbreaking solutions to advance women's health, today announced the launch of its Consumer Advocacy Campaign for Pelvic Organ Prolapse Awareness and Education.

Key Points: 
  • NEWARK, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- FEMSelect Ltd., a women-led company developing groundbreaking solutions to advance women's health, today announced the launch of its Consumer Advocacy Campaign for Pelvic Organ Prolapse Awareness and Education.
  • To kick off the campaign, which will highlight pelvic organ prolapse and its treatment options, FEMSelect today released the results of a national awareness survey that polled women aged 45 and older across the United States regarding their awareness and education on pelvic organ prolapse.
  • 18.50% of those surveyed said they are not aware of any treatment options for pelvic organ prolapse.
  • The study's findings underscore the urgent need for enhanced public awareness campaigns and proactive healthcare provider communication regarding pelvic organ prolapse and pelvic floor dysfunction.

Escala Medical Awarded €5.5 Million EIC Funding to Revolutionize Pelvic Organ Prolapse Treatment

Retrieved on: 
Monday, June 26, 2023
Femtech, Quality of life, Woman, European Innovation Council, Patient, EIC, FDA, POP, Pelvic organ prolapse, Pharmaceutical industry, Escala

Escala is at the forefront of the pelvic organ prolapse (POP) treatment revolution.

Key Points: 
  • Escala is at the forefront of the pelvic organ prolapse (POP) treatment revolution.
  • Escala Medical's breakthrough device brings incision-free pelvic organ prolapse treatment to women suffering from this widespread and debilitating condition, affecting approximately 50% of women worldwide.
  • Current surgical treatment options for POP are invasive and principally suitable for advanced stage prolapse.
  • It propels us forward in our mission to provide durable, incisionless treatments for patients suffering from pelvic organ prolapse, effectively enhancing their quality of life."

LevLane Advertising Appointed Agency of Record by FEMSelect Ahead of Consumer Advocacy Campaign

Retrieved on: 
Thursday, June 22, 2023
Agency of record, Vagina, Femtech, Marketing, Woman, SEO, Prolapse, SEM, Physician, Advertising, Pelvic organ prolapse, Health, FDA, Social media, Female, Pharmaceutical industry, Sales

PHILADELPHIA, June 22, 2023 (GLOBE NEWSWIRE) -- FEMSelect, a women's health company dedicated to providing safe and effective health solutions, has appointed award-winning LevLane Advertising as its Agency of Record.

Key Points: 
  • PHILADELPHIA, June 22, 2023 (GLOBE NEWSWIRE) -- FEMSelect, a women's health company dedicated to providing safe and effective health solutions, has appointed award-winning LevLane Advertising as its Agency of Record.
  • LevLane Advertising is a full-service Philadelphia-based advertising agency renowned for its expertise in strategic marketing and communications.
  • LevLane will spearhead the U.S. consumer advocacy campaign for EnPlace®, a minimally invasive and meshless approach for pelvic floor ligament fixation, in select markets where physicians have been educated on its use.
  • "Working with LevLane is a natural choice for us ahead of our consumer advocacy launch, as we share not only a mutual vision, but also key core values,” said Debbie Garner, co-CEO of FEMSelect.